Foghorn Therapeutics Inc. Increase Decrease In Operating Lease Liability
Foghorn Therapeutics Inc. (FHTX) reported Increase Decrease In Operating Lease Liability of $1.63 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-06
- Foghorn Therapeutics Inc. increase decrease in operating lease liability for the quarter ending 2026-06-30 was $1.00M.
- Foghorn Therapeutics Inc. increase decrease in operating lease liability for the quarter ending 2026-03-31 was $621.00K.
- Foghorn Therapeutics Inc. increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$941.00K.
- Foghorn Therapeutics Inc. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$1.17M.
- Foghorn Therapeutics Inc. increase decrease in operating lease liability for fiscal 2025 was -$6.74M.
- Foghorn Therapeutics Inc. increase decrease in operating lease liability for fiscal 2024 was -$7.94M.
- Foghorn Therapeutics Inc. increase decrease in operating lease liability for fiscal 2023 was -$7.51M.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $1.63M 10-Q · filed 2026-08-06 | $685.00K derived: sum of 3 quarters · filed 2026-08-06 | -$484.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $621.00K 10-Q · filed 2026-05-07 | -$320.00K derived: sum of 2 quarters · filed 2026-05-07 | -$1.49M derived: sum of 3 quarters · filed 2026-05-07 | -$3.84M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$941.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | -$2.11M derived: sum of 2 quarters · filed 2026-03-11 | -$4.46M derived: sum of 3 quarters · filed 2026-08-06 | -$6.74M 10-K · filed 2026-03-11 |
| 2025-09-30 | -$1.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$3.52M derived: sum of 2 quarters · filed 2026-08-06 | -$5.80M 10-Q · filed 2025-11-05 | -$7.74M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$2.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$4.63M 10-Q · filed 2026-08-06 | -$6.57M derived: sum of 3 quarters · filed 2026-08-06 | -$8.38M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$2.28M 10-Q · filed 2026-05-07 | -$4.22M derived: sum of 2 quarters · filed 2026-05-07 | -$6.02M derived: sum of 3 quarters · filed 2026-05-07 | -$8.13M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$1.94M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | -$3.75M derived: sum of 2 quarters · filed 2026-03-11 | -$5.85M derived: sum of 3 quarters · filed 2026-03-11 | -$7.94M 10-K · filed 2026-03-11 |
| 2024-09-30 | -$1.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$3.91M derived: sum of 2 quarters · filed 2025-11-05 | -$6.00M 10-Q · filed 2025-11-05 | -$8.01M derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | -$2.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$4.20M 10-Q · filed 2025-08-05 | -$6.21M derived: sum of 3 quarters · filed 2025-08-05 | -$8.15M derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | -$2.09M 10-Q · filed 2025-05-14 | -$4.10M derived: sum of 2 quarters · filed 2025-05-14 | -$6.04M derived: sum of 3 quarters · filed 2025-05-14 | -$7.94M derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | -$2.01M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | -$3.95M derived: sum of 2 quarters · filed 2025-03-06 | -$5.85M derived: sum of 3 quarters · filed 2025-03-06 | -$7.51M 10-K · filed 2025-03-06 |
| 2023-09-30 | -$1.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | -$3.84M derived: sum of 2 quarters · filed 2024-11-04 | -$5.50M 10-Q · filed 2024-11-04 | |
| 2023-06-30 | -$1.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$3.56M 10-Q · filed 2024-08-08 | ||
| 2023-03-31 | -$1.67M 10-Q · filed 2024-05-06 | |||
| 2022-09-30 | -$1.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$3.56M derived: sum of 2 quarters · filed 2023-11-02 | -$5.31M 10-Q · filed 2023-11-02 | |
| 2022-06-30 | -$1.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | -$3.52M 10-Q · filed 2023-08-04 | ||
| 2022-03-31 | -$1.75M 10-Q · filed 2023-05-08 | |||
| 2021-09-30 | -$1.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$2.33M 10-Q · filed 2022-11-08 | ||
| 2021-06-30 | -$725.00K 10-Q · filed 2022-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |